Dec 9 2007
Millipore Corporation and Rohm and Haas Company today announced a joint development agreement to create new high-performance chromatography products that are used to manufacture biologic drugs. The strength of this partnership lies in combining Millipore’s biopharmaceutical manufacturing expertise with Rohm and Haas’ knowledge of ion exchange resins, polymer chemistry and manufacturing.
Under the terms of the agreement, Millipore’s Bioprocess Division and Rohm and Haas Ion Exchange Resins will develop improved Ion Exchange chromatography products for manufacturing biologic drugs. Millipore will gain exclusive access to new, customized chromatography media developed under the agreement. Ion exchange is used to separate molecules based on their molecular charge and is a critical step in purifying biologic drugs.
“By combining our capabilities with Rohm and Haas’ expertise, we will significantly broaden the chromatography offerings we can provide to our biotech and pharmaceutical customers,” said Jean-Paul Mangeolle, President of Millipore’s Bioprocess Division. “These new ion exchange offerings will build on our strong position in Protein Affinity chromatography and take us a step closer to providing complete, integrated solutions for our biopharmaceutical customers.”
“Millipore’s market insights and deep understanding of biopharmaceuticals customers’ needs will accelerate the development of new advanced separation media,” adds Kim Ann Mink, Vice President and Global General Manager, Rohm and Haas Ion Exchange Resins. “We are confident this collaboration will yield developments that will benefit customers and our respective companies.”
Millipore, with its extensive experience in downstream processing, including filtration, chromatography, and disposable manufacturing, brings significant expertise in enabling pharmaceutical and biotechnology companies to optimize their manufacturing productivity, ensure the quality of drugs, and scale up the production of biologic drugs.
Rohm and Haas, the worldwide leader in ion exchange resins technology has extensive experience in polymer chemistry and functional beads. Rohm and Haas has the capacity to develop, manufacture and supply superior performance separation media from analytical to large scale quantities, which can increase output purity and yield, lower production costs, and facilitate compliance with the most stringent regulations.